{"id":3445,"date":"2019-05-23T09:26:23","date_gmt":"2019-05-23T08:26:23","guid":{"rendered":"https:\/\/www.cilcare.com\/?p=3445"},"modified":"2019-05-23T09:26:23","modified_gmt":"2019-05-23T08:26:23","slug":"cilcare-at-the-stp-38th-annual-symposium","status":"publish","type":"post","link":"https:\/\/www.cilcare.com\/jp\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/","title":{"rendered":"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC"},"content":{"rendered":"<p>Join <strong><a href=\"https:\/\/www.cilcare.com\/jp\/\">CILcare<\/a><\/strong> \u306e\u4e88\u9632\u304a\u3088\u3073\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002 <a href=\"http:\/\/cbset.org\"><strong>CBSET<\/strong><\/a> at the <strong><a href=\"https:\/\/www.toxpath.org\/AM2019\/index.asp\">STP 38th Annual Symposium<\/a><\/strong> on June 22-27, 2019 in Raleigh, North Carolina. Meet our experts to learn about our\u00a0<strong>cutting-edge GLP preclinical services<\/strong>\u00a0for the evaluation of hearing disorders and regenerative therapies.<\/p>\n<p>&nbsp;<\/p>\n<p><strong><a href=\"https:\/\/www.cilcare.com\/jp\/our-team\/\">Suchi RAGHUNATHAN<\/a>,<\/strong> Ph.D, CILcare&#8217;s Scientist and<strong> <a href=\"https:\/\/www.cilcare.com\/jp\/our-team\/\">Cyrille SAGE<\/a>,<\/strong> Ph.D, CILcare&#8217;s R&amp;D Project Manager, Senior Scientist will be presenting a poster: &#8220;<strong>Ototoxicity Related to Cisplatin: Does Gender Matter?<\/strong>&#8220;.<\/p>\n<p>Cisplatin is a first-line treatment of several cancers. Adverse effects include nephrotoxicity, neurotoxicity, and ototoxicity with no preventative treatment for the latter. Cisplatin treatment often results in a bilateral elevation of hearing threshold resulting in irreversible hearing loss.<\/p>\n<p>&nbsp;<\/p>\n<p>John Keating, DVM, DACVP, CBSET\u2019s Director of Pathology, is speaking on: <strong>\u201c<\/strong><strong>Medical Device Safety Assessment: The Frontiers of Safety Assessment Pathology\u201d<\/strong>\u00a0on Sunday June 23, from\u00a011:30 AM\u201312:00 Noon during the session on Hernia Mesh Implants.<\/p>\n<p>&nbsp;<\/p>\n<p>Join<a href=\"https:\/\/www.cilcare.com\/jp\/\"> CILcare<\/a> \u306e\u4e88\u9632\u304a\u3088\u3073\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002 <a href=\"http:\/\/cbset.org\">CBSET<\/a> at<strong> booth #300<\/strong>. Our experts will be\u00a0pleased to discuss how\u00a0<strong>the leaders in\u00a0<a href=\"https:\/\/www.cilcare.com\/jp\/our-services\/glp-toxicology-studies\/\">GLP ototoxicity studies<\/a><\/strong>\u00a0can help you advance your novel therapies through early efficacy trials and GLP safety assessment.<\/p>\n<blockquote>\n<h2 class=\"p1\">About <a href=\"https:\/\/www.toxpath.org\/AM2019\/index.asp\">STP 38th Annual Symposium<\/a><\/h2>\n<\/blockquote>\n<p>The 38th\u00a0Annual Symposium of the Society of Toxicologic Pathology will take place in Raleigh, North Carolina\u00a0on June 22-27, 2019.\u00a0 The theme for the 2019\u00a0Annual Symposium is &#8220;Environmental Toxicologic Pathology and One Health&#8221;\u00a0and promises to be another dynamic meeting with excellent scientific sessions, continuing education courses, and many networking opportunities.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Join CILcare and CBSET at the STP 38th Annual Symposium on June 22-27, 2019 in Raleigh, North Carolina. Meet our experts to learn about our\u00a0cutting-edge GLP preclinical services\u00a0for the evaluation of hearing disorders and regenerative therapies. &nbsp; Suchi RAGHUNATHAN, Ph.D, CILcare&#8217;s Scientist and Cyrille SAGE, Ph.D, CILcare&#8217;s R&amp;D Project Manager, Senior Scientist will be presenting a poster: &#8220;Ototoxicity Related to Cisplatin: Does Gender Matter?&#8220;. Cisplatin is a first-line treatment of several cancers. Adverse effects include nephrotoxicity, neurotoxicity, and ototoxicity with no preventative treatment for the latter. Cisplatin treatment often results in a bilateral elevation of hearing threshold resulting in irreversible hearing loss. &nbsp; John Keating, DVM, DACVP, CBSET\u2019s Director of [&hellip;]<\/p>","protected":false},"author":3,"featured_media":3446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-3445","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC - Cilcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC - Cilcare\" \/>\n<meta property=\"og:description\" content=\"Join CILcare and CBSET at the STP 38th Annual Symposium on June 22-27, 2019 in Raleigh, North Carolina. Meet our experts to learn about our\u00a0cutting-edge GLP preclinical services\u00a0for the evaluation of hearing disorders and regenerative therapies. &nbsp; Suchi RAGHUNATHAN, Ph.D, CILcare&#8217;s Scientist and Cyrille SAGE, Ph.D, CILcare&#8217;s R&amp;D Project Manager, Senior Scientist will be presenting a poster: &#8220;Ototoxicity Related to Cisplatin: Does Gender Matter?&#8220;. Cisplatin is a first-line treatment of several cancers. Adverse effects include nephrotoxicity, neurotoxicity, and ototoxicity with no preventative treatment for the latter. Cisplatin treatment often results in a bilateral elevation of hearing threshold resulting in irreversible hearing loss. &nbsp; John Keating, DVM, DACVP, CBSET\u2019s Director of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-23T08:26:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"564\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"CILcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"CILcare\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/\",\"url\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/\",\"name\":\"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png\",\"datePublished\":\"2019-05-23T08:26:23+00:00\",\"author\":{\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png\",\"width\":960,\"height\":564,\"caption\":\"STP\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\",\"name\":\"CILcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"caption\":\"CILcare\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC - Cilcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/","og_locale":"ja_JP","og_type":"article","og_title":"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC - Cilcare","og_description":"Join CILcare and CBSET at the STP 38th Annual Symposium on June 22-27, 2019 in Raleigh, North Carolina. Meet our experts to learn about our\u00a0cutting-edge GLP preclinical services\u00a0for the evaluation of hearing disorders and regenerative therapies. &nbsp; Suchi RAGHUNATHAN, Ph.D, CILcare&#8217;s Scientist and Cyrille SAGE, Ph.D, CILcare&#8217;s R&amp;D Project Manager, Senior Scientist will be presenting a poster: &#8220;Ototoxicity Related to Cisplatin: Does Gender Matter?&#8220;. Cisplatin is a first-line treatment of several cancers. Adverse effects include nephrotoxicity, neurotoxicity, and ototoxicity with no preventative treatment for the latter. Cisplatin treatment often results in a bilateral elevation of hearing threshold resulting in irreversible hearing loss. &nbsp; John Keating, DVM, DACVP, CBSET\u2019s Director of [&hellip;]","og_url":"https:\/\/www.cilcare.com\/jp\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/","og_site_name":"Cilcare","article_published_time":"2019-05-23T08:26:23+00:00","og_image":[{"width":960,"height":564,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png","type":"image\/png"}],"author":"CILcare","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"CILcare","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/","url":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/","name":"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png","datePublished":"2019-05-23T08:26:23+00:00","author":{"@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac"},"breadcrumb":{"@id":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2019\/05\/STP2.png","width":960,"height":564,"caption":"STP"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/2019\/05\/23\/cilcare-at-the-stp-38th-annual-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Meet CILcare at the STP 38th Annual Symposium on June 22-27,2019 in Ralegh, NC"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac","name":"CILcare","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","caption":"CILcare"}}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/3445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=3445"}],"version-history":[{"count":0,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/3445\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/3446"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=3445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/categories?post=3445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/tags?post=3445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}